SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001185185-15-002462
Filing Date
2015-09-30
Accepted
2015-09-30 14:33:22
Documents
1
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form3-deltagroup093015.html 3  
1 OWNERSHIP DOCUMENT form3-deltagroup093015.xml 3 4446
  Complete submission text file 0001185185-15-002462.txt   6521
Mailing Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140
Business Address 13565 SW TUALATIN-SHERWOOD RD. SUITE 800 SHERWOOD OR 97140 844-559-9910
Entia Biosciences, Inc. (Issuer) CIK: 0001408299 (see all company filings)

IRS No.: 260561199 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address ROOM 2204, WEST TOWER, SHUN TAK CENTRE 200 CONNAUGHT ROAD CENTRAL, SHEUNG WAN HONG KONG K3 00000
Business Address ROOM 2204, WEST TOWER, SHUN TAK CENTRE 200 CONNAUGHT ROAD CENTRAL, SHEUNG WAN HONG KONG K3 00000 852 28106226
Delta Group Investments Ltd (Reporting) CIK: 0001650950 (see all company filings)

State of Incorp.: D8 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-52864 | Film No.: 151133434